TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
2012 · BMC Cancer · 22 citations
https://doi.org/10.1186/1471-2407-12-85
A
A Glässner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
977
Citations
16
h-index
19
i10-index
A Glässner is an academic researcher. The author has contributed to research in topics: Immune Cell Function and Interaction & Hepatitis C virus research & Liver Disease Diagnosis and Treatment. The author has an h-index of 16, co-authored 70 publications.
Papers by this author
worksAnalysis of differential gene expression of PBMC for the in vitro detection of drug sensitization
2025 · Allergology International · 2 citations
https://doi.org/10.1016/j.alit.2024.11.006
CXCR3(+)CD56Bright NK cells have strong anti-fibrotic potential.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0038846.g002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat